• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

半乳糖凝集素在黑色素瘤进展中的甜与苦两面。

The sweet and bitter sides of galectins in melanoma progression.

机构信息

Department of Cancer Biology, The University of Texas at MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Pigment Cell Melanoma Res. 2012 Sep;25(5):592-601. doi: 10.1111/j.1755-148X.2012.01026.x. Epub 2012 Jul 12.

DOI:10.1111/j.1755-148X.2012.01026.x
PMID:22672152
Abstract

Melanoma is the leading cause of skin cancer-related deaths, which is due in large part to its aggressive behavior, resistance to therapy, and ability to metastasize to multiple organs such as the lymph nodes, lung, and brain. Melanoma progresses in a stepwise manner from the benign nevus, to radial spreading through the dermis, to a vertical invasive phase, and finally to metastasis. The carbohydrate-binding family of galectins has a strong influence on each phase of melanoma progression through their effects on immune surveillance, angiogenesis, cell migration, tumor cell adhesion, and the cellular response to chemotherapy. Galectins share significant homology in their carbohydrate recognition domain (CRD), which mediates binding to an array of N-glycosylated proteins located on the surface of tumor cells, endothelial cells, T-cells, and to similarly glycosylated extracellular matrix proteins. Galectins are also present within tumor cells where they perform anti-apoptotic functions and enhance intracellular signaling that results in deregulated expression of genes involved in tumor progression. The most extensively studied galectins, galectin-1 and galectin-3, have been shown to have profound effects on melanoma growth and metastasis by influencing many of these biological processes.

摘要

黑色素瘤是皮肤癌相关死亡的主要原因,这在很大程度上是由于其侵袭性行为、对治疗的耐药性以及向多个器官(如淋巴结、肺和脑)转移的能力。黑色素瘤从良性痣逐步进展,通过真皮向放射性扩散,进入垂直侵袭阶段,最终转移。糖结合家族的半乳糖凝集素通过对免疫监视、血管生成、细胞迁移、肿瘤细胞黏附以及细胞对化疗的反应的影响,对黑色素瘤进展的每个阶段都有很强的影响。半乳糖凝集素在其碳水化合物识别结构域(CRD)中有很高的同源性,该结构域介导与位于肿瘤细胞、内皮细胞、T 细胞表面的一系列 N-糖基化蛋白以及类似糖基化的细胞外基质蛋白的结合。半乳糖凝集素也存在于肿瘤细胞内,在那里它们发挥抗细胞凋亡功能,并增强细胞内信号转导,导致参与肿瘤进展的基因表达失调。研究最广泛的半乳糖凝集素——半乳糖凝集素-1 和半乳糖凝集素-3——通过影响许多这些生物学过程,对黑色素瘤的生长和转移有深远的影响。

相似文献

1
The sweet and bitter sides of galectins in melanoma progression.半乳糖凝集素在黑色素瘤进展中的甜与苦两面。
Pigment Cell Melanoma Res. 2012 Sep;25(5):592-601. doi: 10.1111/j.1755-148X.2012.01026.x. Epub 2012 Jul 12.
2
Vascular galectins: regulators of tumor progression and targets for cancer therapy.血管半乳糖凝集素:肿瘤进展的调节剂和癌症治疗的靶点。
Cytokine Growth Factor Rev. 2013 Dec;24(6):547-58. doi: 10.1016/j.cytogfr.2013.07.003. Epub 2013 Aug 12.
3
Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells.复杂N-聚糖是中国仓鼠卵巢细胞上半乳糖凝集素-1、-3和-8的主要配体。
Glycobiology. 2006 Apr;16(4):305-17. doi: 10.1093/glycob/cwj063. Epub 2005 Nov 29.
4
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.半乳糖凝集素-3的表达与黑色素瘤的肿瘤进展及阳光暴露模式相关。
Clin Cancer Res. 2006 Nov 15;12(22):6709-15. doi: 10.1158/1078-0432.CCR-06-0758.
5
Galectins in apoptosis.半乳糖凝集素与细胞凋亡
Methods Enzymol. 2006;417:256-73. doi: 10.1016/S0076-6879(06)17018-4.
6
Intracellular galectins in cancer cells: potential new targets for therapy (Review).细胞内半乳糖凝集素在癌细胞中的作用:治疗的潜在新靶点(综述)。
Int J Oncol. 2014 Apr;44(4):1001-14. doi: 10.3892/ijo.2014.2267. Epub 2014 Jan 21.
7
Galectins and microenvironmental niches during hematopoiesis.半乳糖凝集素与造血微环境。
Curr Opin Hematol. 2011 Nov;18(6):443-51. doi: 10.1097/MOH.0b013e32834bab18.
8
Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.半乳糖凝集素作为小鼠乳腺癌侵袭性的标志物:迈向人乳腺癌的凝集素靶向治疗
Breast Cancer Res Treat. 2005 Jun;91(3):227-41. doi: 10.1007/s10549-005-0289-8.
9
Galectin-7 in Epithelial Homeostasis and Carcinomas.半乳糖凝集素-7 在上皮稳态和癌中的作用。
Int J Mol Sci. 2017 Dec 19;18(12):2760. doi: 10.3390/ijms18122760.
10
Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.载有半乳糖凝集素的细胞作为通过荧光新糖缀合物分析凝集素特异性的平台:以半乳糖凝集素-1和-3为例及分析设置的影响
Glycobiology. 2008 Apr;18(4):315-24. doi: 10.1093/glycob/cwn009. Epub 2008 Feb 6.

引用本文的文献

1
Melanoma Glycome Regulates the Pro-Oncogenic Properties of Extracellular Galectin-3.黑色素瘤糖组调节细胞外半乳糖凝集素-3的促癌特性。
Int J Mol Sci. 2025 May 19;26(10):4882. doi: 10.3390/ijms26104882.
2
The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma.半乳糖凝集素-3 在黑色素瘤进展中的多效作用:揭开谜团。
Adv Cancer Res. 2023;157:157-193. doi: 10.1016/bs.acr.2022.06.001. Epub 2022 Aug 8.
3
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma.
缺氧控制糖组学特征和半乳糖凝集素-8 配体轴促进转移性黑色素瘤的促肿瘤特性。
J Invest Dermatol. 2023 Mar;143(3):456-469.e8. doi: 10.1016/j.jid.2022.07.033. Epub 2022 Sep 27.
4
Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines.黑色素瘤细胞系中恩考芬尼和比美替尼联合治疗期间与获得性耐药相关的分子改变
Cancers (Basel). 2021 Dec 1;13(23):6058. doi: 10.3390/cancers13236058.
5
The role of tumor microenvironment in melanoma therapy resistance.肿瘤微环境在黑色素瘤治疗耐药中的作用。
Melanoma Manag. 2016 Mar;3(1):23-32. doi: 10.2217/mmt.15.37. Epub 2016 Feb 12.
6
The Role of Galectins in Cervical Cancer Biology and Progression.半乳糖凝集素在宫颈癌生物学和进展中的作用。
Biomed Res Int. 2018 May 8;2018:2175927. doi: 10.1155/2018/2175927. eCollection 2018.
7
Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells.半乳糖凝集素-3对食管癌细胞血管生成拟态的影响。
Oncol Lett. 2018 Apr;15(4):4907-4911. doi: 10.3892/ol.2018.7959. Epub 2018 Feb 6.
8
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes.联合抗 VEGF 和抗 CTLA-4 治疗引发针对半乳糖凝集素-1 的体液免疫,与有利的临床结局相关。
Cancer Immunol Res. 2017 Jun;5(6):446-454. doi: 10.1158/2326-6066.CIR-16-0385. Epub 2017 May 4.
9
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma.吲哚胺2,3-双加氧酶(IDO)和半乳糖凝集素-3阻碍了转移性黑色素瘤过继性细胞治疗中临床级肿瘤特异性T细胞的体外生成。
Cancer Immunol Immunother. 2017 Jul;66(7):913-926. doi: 10.1007/s00262-017-1995-x. Epub 2017 Apr 11.
10
Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.半乳糖凝集素-3的基因沉默改变了Eca109人食管癌细胞的生物学行为。
Mol Med Rep. 2016 Jan;13(1):160-6. doi: 10.3892/mmr.2015.4543. Epub 2015 Nov 10.